Search clinical trials for: Sublingual Buprenorphine

Total 750 results

Virginia Commonwealth University

Completed

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Drug Overdose | Opioid-use Disorder | Opioid Withdrawal

United States
University of Pittsburgh
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Buprenorphine for Late-Life Treatment Resistant Depression (BUILD)

Depression

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Buprenorphine Maintenance for Opiate Dependence - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Mundipharma Korea Ltd

Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (NOBLE)

Spinal Disorder

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
University of California, San Diego
Society of Family Planning

Completed

Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion (ABCD&E)

Procedural Pain | Buprenorphine | Dilation and Evacuation | Analgesics | Adjuvants, Anesthesia

United States
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Opioid Use Disorder
University Hospital, Clermont-Ferrand

Active, not recruiting

High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (SEVROP)

High Dosage Buprenorphine

France
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
Mundipharma Research Limited

Terminated

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (BUP1501)

Chemotherapy Induced Mucositis | Mouth Pain

Denmark, United Kingdom
Chong Kun Dang Pharmaceutical

Completed

CKD-337 Drug Interaction Study

Dyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Healthy

Germany
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Healthy

Germany
Danish University of Pharmaceutical Sciences

Unknown

Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers

Healthy Volunteers

Denmark
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
Apnimed

Completed

Crossover Trial of AD036 in Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Technological Centre of Nutrition and Health, Spain
University Rovira i Virgili; Hospital Universitari Sant Joan de Reus; Fundació... and other collaborators

Completed

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN) (MELATONIN)

Biological Availability

Spain
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Seoul National University Hospital

Recruiting

Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients

Complex Regional Pain Syndromes

Korea, Republic of
Peter Rossing

Completed

Microalbuminuria and Allopurinol in Type 1 Diabetes (MIKAL)

Type 1 Diabetes | Diabetic Nephropathy

Denmark
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Heroin Dependence | Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

IV Cocaine Abuse: A Laboratory Model - 3

Cocaine-Related Disorders

United States
Tehran University of Medical Sciences

Completed

Buprenorphine in Acute Renal Colic Pain Management

Renal Colic | Acute Pain Management

Iran, Islamic Republic of
Norpharma A/S
Mundipharma Finland

Completed

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine

Pain | Osteoarthritis

Finland
Biohaven Pharmaceuticals, Inc.

No longer available

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis | ALS | Lou Gehrig Disease | Lou Gehrig's Disease | Lou-Gehrigs Disease | Motor Neuron Disease, Amyotrophic Lateral Sclerosis
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
Georgetown University
National Institute on Drug Abuse (NIDA)

Terminated

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Pain | Buprenorphine

United States

Search clinical trials for: Sublingual Buprenorphine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations